Liven Pharma Limited (PSX:LIVEN)

Liven Pharma Revenue

Liven Pharma had revenue of 29.25M PKR in the quarter ending March 31, 2026, with 98.22% growth. This brings the company's revenue in the last twelve months to 99.11M, down -72.91% year-over-year. In the fiscal year ending June 30, 2025, Liven Pharma had annual revenue of 127.27M, down -48.07%.

• Revenue (ttm): 99.11M
• Revenue Growth: -72.91%
• P/S Ratio: 42.65
• Revenue / Employee: 2.42M
• Employees: 41
• Market Cap: 4.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	127.27M	-117.82M	-48.07%
Jun 30, 2024	245.09M	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error